Ruxolitinib in adult patients with secondary hemophagocytic lymphohistiocytosis.

Boonstra, Philip S; Ahmed, Asra; Merrill, Samuel A; Wilcox, Ryan A

Boonstra, Philip S; Ahmed, Asra; Merrill, Samuel A; Wilcox, Ryan A.

Boonstra PS; Department of Biostatistics and the Center for Cancer Biostatistics, University of Michigan, Ann Arbor, Michigan.
Ahmed A; Division of Hematology/Medical Oncology, Department of Internal Medicine, University of Michigan Rogel Cancer Center, Ann Arbor, Michigan.
Merrill SA; The Section of Hematology, Department of Medicine, West Virginia University, Morgantown, West Virginia.
Wilcox RA; Division of Hematology/Medical Oncology, Department of Internal Medicine, University of Michigan Rogel Cancer Center, Ann Arbor, Michigan.

Am J Hematol ; 96(4): E103-E105, 2021 04 01.

Article in English | MEDLINE | ID: covidwho-1198355

Subject(s)

Lymphohistiocytosis, Hemophagocytic/drug therapy; Protein Kinase Inhibitors/therapeutic use; Pyrazoles/therapeutic use; Adult; COVID-19; Clinical Trials as Topic/statistics & numerical data; Cytokine Release Syndrome/drug therapy; Cytokine Release Syndrome/etiology; Female; Humans; Lymphohistiocytosis, Hemophagocytic/complications; Male; Nitriles; Pilot Projects; Progression-Free Survival; Prospective Studies; Protein Kinase Inhibitors/adverse effects; Pyrazoles/adverse effects; Pyrimidines; Recurrence; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pyrazoles / Protein Kinase Inhibitors / Lymphohistiocytosis, Hemophagocytic Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adult / Female / Humans / Male Language: English Journal: Am J Hematol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google